Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A yearly injection such as Lenacapavir could help overcome barriers to PrEP accessibility by increasing its uptake and making ...

The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives ...

A South African Medical Research Council (SAMRC) study has revealed that HIV remains one of the leading causes of death in ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Antiviral treatments strive to block a virus or halt its replication ... reveals significant progress in the global fight against HIV/AIDS, alongside a stark warning that current trends indicate ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

AIDS advocates are fearful that budget cuts being pushed by Republicans will gut essential health care services in the United ...

Hundreds of HIV doctors and researchers have called on the Trump administration to reverse its sweeping aid funding cuts, saying they are "doing catastrophic harm" to the global fight against AIDS.

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

March is a significant month for women's health, observing International Women's Day and National Women's HIV/AIDS Awareness ...